Home Trending Stocks Aerpio Pharmaceuticals Inc. (ARPO) stock surged in the current trading session; here’s...

Aerpio Pharmaceuticals Inc. (ARPO) stock surged in the current trading session; here’s why

At last check, in the current trading session, Aerpio Pharmaceuticals Inc. (ARPO) stock had surged by 48.70% to $1.72. ARPO stock previously closed the session at $1.16. The stock volume traded 96.55 million shares. In the past year, up-to-date ARPO shares surged by 59.45% and in the past week, they moved up by 10.48%. In the past three and six months, the stock has shed -42.86% and -14.07%. Furthermore, Aerpio Pharmaceuticals is currently valued at $50.60 million and has 47.17 million outstanding shares.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What you need to know about Aerpio Pharmaceuticals

Aerpio Pharmaceuticals, Inc., a biopharmaceutical company that specifically focuses on the development and marketing of products and treatments for unmet needs and diseases. The treatments include therapeutic and novel compounds for the treatment of ocular diseases and diabetic disorders. Aerpio Pharmaceuticals is headquartered in Cincinnati, Ohio.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

ARPO’s lead candidates and product offerings

Razuprotafib is a small molecule and a Tie2 pathway activator. It is the company’s lead product candidate that has Phase IIb clinical trial for the treatment of diabetic retinopathy which has been completed.

Products other than the lead candidate include ARP-1536 which is in development for the treatment of diabetic vascular complications. ARP-1536 is a humanized monoclonal antibody that is in the preclinical development stage.

ARPO stock also produces a selective stabilizer of hypoxia-inducible factor-1 alpha, known as GB004. It is used for the treatment of inflammatory bowel disease and is currently in Phase 1b clinical trial

Furthermore, there are bispecific antibodies made by APRO stock for the treatment of wet age-related macular degeneration and DME through intravitreal injection.

Aerpio Pharmaceuticals, Inc. has collaborated with Quantum Leap Healthcare Collaborative for the evaluation of razuprotafib in the treatment of acute respiratory distress syndrome in adult patients with moderate to severe COVID-19.

Announcement of the merger agreement with Aadi Bioscience

Today, 17th May 2021, Aerpio has announced that it is being acquired by Aadi Bioscience through a definitive merger agreement. The joined public organization will zero in on propelling Aadi’s lead item up-and-comer, FYARROTM. Following the proposed merger, Aerpio will change its name to “Aadi Bioscience, Inc.” Upon shutting of the exchange, the joined organization will be driven by Aadi’s CEO, Neil Desai, and settled in Los Angeles, California.

Aerpio’s governing body persistently attempted an extensive vital survey and has inferred that the proposed exchange with Aadi is to the greatest advantage of ARPO stockholders and investors. Aerpio’s BOD accepts that Aadi’s late-stage advancement program may offer huge health advantage to PEComa patients and significant potential for patients with tumors holding TSC1 or TSC2 inactivating changes.

All together with famous institutional financial backers, ARPO stock will join forces with Aadi as it propels FYARRO and endeavors to open the capability of mTOR as a helpful objective.

On the side of the consolidation, Aerpio has gone into subscription agreements to bring $155 million up in a Private Investment in Public Equity (PIPE) financing led by Acuta Capital Partners and KVP Capital and including Avoro Capital Advisors.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Along with the money anticipated from the two organizations at closing, the net proceeds of the PIPE financing are relied upon to fund the organization into 2024, empowering expected endorsement and business dispatch in PEComa just as culmination of a registrational preliminary in tumors holding TSC1 or TSC2 inactivating adjustments.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

Roblox Corp. (NASDAQ: RBLX) stock falls during pre-market trading session. What’s happening?

Roblox Corp. (NASDAQ: RBLX) stock gained by 2.28% at last close while the RBLX stock price declines by 8.13% in the pre-market trading session....

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

TAL Education Group (TAL) stock is tumbling today: What’s Going on?

Shares of the TAL Education Group (TAL) stock were tumbling in the current market trading session today on June 16, 2021, without any obvious...

SPI Energy Inc. (SPI) stock surged in the current market trading. Here’s the update

SPI Energy Inc. (NASDAQ: SPI) stock soars by 15.42% during the current market trading session. SPI Energy is an international renewable energy company that...

Related News

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

Roblox Corp. (NASDAQ: RBLX) stock falls during pre-market trading session. What’s happening?

Roblox Corp. (NASDAQ: RBLX) stock gained by 2.28% at last close while the RBLX stock price declines by 8.13% in the pre-market trading session....

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam